News on Immunology continually updated from thousands of sources around the net.
3 hrs ago | Customer Interaction Solutions
Ltd. today announced that the Company will host a conference call at 10:00 AM EDT on Tuesday, August 5, 2014 to review the second quarter 2014 results.
Dr. Crystal most recently served in the Global Business Development Product Acquisition & Licensing team at G.E. Life Sciences.
Fifteen years ago, MIT professor John Essigmann and colleagues from the University of Washington had a novel idea for an HIV drug.
A nurse from Liberia walks to spray preventives to disinfect the waiting area for visitors at the ELWA Hospital, where Dr. Kent Bradley is being quarantined after contracting the Ebola virus.
Every weekday at 8 a.m., the researcher climbs onto the roof of Allegheny General Hospital in Pittsburgh to check a machine called a Burkard Spore Trap.
New research by experts at The University of Nottingham could offer new clues for the treatment of a rare genetic disease.
Tel Aviv University's Sackler Medical Faculty is 50 years old but constantly innovating and looking to the future, says outgoing dean Prof.
As the grass pollen season retreats, weeds make their advance, providing more fodder for thunderstorm asthma.
This summer high school students from around the Bay Area are interning at labs and departments across Stanford.
Toxoplasma gondii is a parasite found in cat poop that can make both people and cats ill.
Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells.
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
Patients with aspirin-exacerbated respiratory disease - a triad of asthma, aspirin sensitivity, and nasal polyposis - usually will tolerate celecoxib better than meloxicam, according to a meta-analysis in the Journal of Allergy and Clinical Immunology .
A vaccine for dust. mite allergy might soon be available Dust mite allergy could soon be a thing of the past thanks to a new vaccine.
Science and industry are collaborating to develop future pharmaceuticals for treating chronic inflammatory diseases.
Scientists at Duke Medicine have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected.
Updated: Tue Jul 29, 2014 08:16 am
Copyright © 2014 Topix LLC